Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 551

1.

18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.

Schwarz JK, Lin LL, Siegel BA, Miller TR, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1502-7. doi: 10.1016/j.ijrobp.2008.03.040. Epub 2008 Jun 4.

PMID:
18538498
2.

Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.

Kidd EA, Siegel BA, Dehdashti F, Grigsby PW.

Cancer. 2010 Mar 15;116(6):1469-75. doi: 10.1002/cncr.24972.

3.
4.

Sequential FDG-PET brachytherapy treatment planning in carcinoma of the cervix.

Lin LL, Mutic S, Malyapa RS, Low DA, Miller TR, Vicic M, Laforest R, Zoberi I, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1494-501. Epub 2005 Sep 12.

PMID:
16154713
5.

Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.

Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):180-6. Epub 2007 Nov 8.

PMID:
17996387
6.

FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy--tumor volume and FDG uptake value.

Sakurai H, Suzuki Y, Nonaka T, Ishikawa H, Shioya M, Kiyohara H, Katoh H, Nakayama Y, Hasegawa M, Nakano T.

Gynecol Oncol. 2006 Mar;100(3):601-7. Epub 2005 Oct 28.

PMID:
16257440
7.

Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.

Bjurberg M, Kjellén E, Ohlsson T, Bendahl PO, Brun E.

Int J Gynecol Cancer. 2009 Dec;19(9):1600-5. doi: 10.1111/IGC.0b013e3181c00359.

PMID:
19955945
8.

Metabolic response of pelvic and para-aortic lymph nodes during radiotherapy for carcinoma of the uterine cervix: using positron emission tomography/computed tomography.

Yoon MS, Nam TK, Chung WK, Jeong SY, Ahn SJ, Nah BS, Song JY, Jeong JU.

Int J Gynecol Cancer. 2011 May;21(4):699-705. doi: 10.1111/IGC.0b013e3181e94349.

PMID:
21546872
9.

F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.

Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW.

Gynecol Oncol. 2006 Apr;101(1):147-51. Epub 2005 Nov 2.

PMID:
16263155
10.

FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.

Yilmaz M, Adli M, Celen Z, Zincirkeser S, Dirier A.

Nucl Med Commun. 2010 Jun;31(6):526-31. doi: 10.1097/MNM.0b013e32833800e7.

PMID:
20215979
11.

New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.

Magné N, Chargari C, Vicenzi L, Gillion N, Messai T, Magné J, Bonardel G, Haie-Meder C.

Cancer Treat Rev. 2008 Dec;34(8):671-81. doi: 10.1016/j.ctrv.2008.08.003. Epub 2008 Oct 11. Review.

PMID:
18849119
12.

Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.

Boughanim M, Leboulleux S, Rey A, Pham CT, Zafrani Y, Duvillard P, Lumbroso J, Haie-Meder C, Schlumberger M, Morice P.

J Clin Oncol. 2008 May 20;26(15):2558-61. doi: 10.1200/JCO.2007.14.3933.

13.

Posttherapy surveillance monitoring of cervical cancer by FDG-PET.

Grigsby PW, Siegel BA, Dehdashti F, Mutch DG.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):907-13.

PMID:
12605968
14.

Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.

Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1506-12.

PMID:
15050330
15.

Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-Fluorodeoxyglucose positron emission tomography: preliminary results in three patients.

Yoshida Y, Kurokawa T, Kawahara K, Yagihara A, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F.

Gynecol Oncol. 2004 Dec;95(3):597-602.

PMID:
15581970
16.

Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.

Yoon MS, Ahn SJ, Nah BS, Chung WK, Song HC, Yoo SW, Song JY, Jeong JU, Nam TK.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e491-7. doi: 10.1016/j.ijrobp.2012.05.041. Epub 2012 Jul 17.

PMID:
22818418
17.

Intratumoral metabolic heterogeneity of cervical cancer.

Kidd EA, Grigsby PW.

Clin Cancer Res. 2008 Aug 15;14(16):5236-41. doi: 10.1158/1078-0432.CCR-07-5252.

18.

The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.

Yao M, Graham MM, Hoffman HT, Smith RB, Funk GF, Graham SM, Dornfeld KJ, Skwarchuk M, Menda Y, Buatti JM.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1001-10.

PMID:
15234033
19.

Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus.

Roedl JB, Halpern EF, Colen RR, Sahani DV, Fischman AJ, Blake MA.

Mol Imaging Biol. 2009 Jan-Feb;11(1):54-60. doi: 10.1007/s11307-008-0169-9. Epub 2008 Sep 4.

PMID:
18769974
20.

Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.

Siva S, Herschtal A, Thomas JM, Bernshaw DM, Gill S, Hicks RJ, Narayan K.

Cancer. 2011 Sep 1;117(17):3981-8. doi: 10.1002/cncr.25991. Epub 2011 Mar 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk